Braskem S.A. reports news on its petrochemical and polymer business, including polyolefins, biopolymers, chemicals, petrochemicals, fuels, industrial utilities, and ADR-related company disclosures. The company’s operating updates commonly reference its Brazil/South America, United States and Europe, and Mexico activities, as well as production and sales trends across petrochemical complexes.
Recurring developments include circular and lower-carbon plastics, I’m green™ bio-based polyethylene, recycled and traditional polyolefins, packaging applications, healthcare and hygiene grades such as Medcol V7040, and collaborations tied to renewable or circular feedstocks. News also covers Form 20-F reporting, annual meeting materials, governance notices, and capital-structure-related communications.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Braskem S.A. has filed its Annual Report on Form 20-F for the year ending December 31, 2022, with the U.S. Securities and Exchange Commission. This filing is crucial for shareholders and the market, providing detailed insights into the company's financial performance and operations over the year. The report is now available on Braskem's Investor Relations website, and shareholders can request a free copy of the audited financial statements included in the report. For any inquiries, the Investor Relations Department can be contacted directly.
Braskem S.A. (NYSE: BAK) reported its 4Q22 earnings, highlighting a significant decline in financial performance. The company recorded a negative Recurring EBITDA of US$32 million, with a full-year EBITDA of US$2.1 billion, down 64% from 2021. Lower demand for petrochemical products, influenced by global market conditions and increased supply, contributed to the downturn. In 2022, Braskem faced a net loss of R$336 million. Despite this, the company maintained a cash position of US$2.4 billion, ensuring financial stability for the next five years. The earnings call is scheduled for March 23, 2023, at 10:00 a.m. ET.
Summary not available.